Drug-Eluting stent lowers restenosis risk to near zero: Data from safety trials suggest stents can challenge the results seen with CABG.(coronary ... An article from: Internal Medicine News
Book Details
Author(s)
Erik L. Goldman
Publisher
International Medical News Group
ISBN / ASIN
B0008EX1V8
ISBN-13
978B0008EX1V7
Availability
Available for download now
Sales Rank
#99,999,999
Marketplace
United States 🇺🇸
Ratings & Reviews
No reviews yet — be the first!
No reviews yet.
Description
This digital document is an article from Internal Medicine News, published by International Medical News Group on February 15, 2002. The length of the article is 1441 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: Drug-Eluting stent lowers restenosis risk to near zero: Data from safety trials suggest stents can challenge the results seen with CABG.(coronary artery bypass graft)
Author: Erik L. Goldman
Publication:Internal Medicine News (Magazine/Journal)
Date: February 15, 2002
Publisher: International Medical News Group
Volume: 35 Issue: 4 Page: 1(2)
Distributed by Thomson Gale
Citation Details
Title: Drug-Eluting stent lowers restenosis risk to near zero: Data from safety trials suggest stents can challenge the results seen with CABG.(coronary artery bypass graft)
Author: Erik L. Goldman
Publication:Internal Medicine News (Magazine/Journal)
Date: February 15, 2002
Publisher: International Medical News Group
Volume: 35 Issue: 4 Page: 1(2)
Distributed by Thomson Gale
